Literature DB >> 18328893

Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases.

Tunc Akkoc1, Pieter J A de Koning, Beate Rückert, Isil Barlan, Mübeccel Akdis, Cezmi A Akdis.   

Abstract

BACKGROUND: A dysregulated and T(H)2-biased immune response appears to be a key pathogenetic factor in atopic diseases. Increased activation and massive infiltration of T cells in the dermis without any evidence for the expansion of their numbers in peripheral blood characterize atopic dermatitis.
OBJECTIVE: To investigate differences and mechanisms of T(H)1 and T(H)2 cell activation-induced cell death (AICD) in atopic disease.
METHODS: Naive (CD4(+)CD45(+)RA) and memory (CD4(+)CD45(+)RO) T cells were isolated from healthy and atopic individuals. T(H)1 and T(H)2 subsets were in vitro differentiated. High IFN-gamma-producing T cells and CXCR3(+) T cells were purified, and AICD of isolated cells was determined in addition to expression of apoptosis receptors and caspase activation.
RESULTS: T(H)1 cells, particularly their high IFN-gamma-producing fraction, and CXCR3(+) T cells showed significantly increased apoptosis in atopic individuals. During their in vitro differentiation, both T(H)1 and T(H)2 cells of atopic individuals showed increased apoptosis compared with the healthy control group, with a significantly high apoptosis in T(H)1 cells. Increased expression of Fas, Fas-ligand, tumor necrosis factor receptor-II, and caspase activation was detected on T(H)1 cells that underwent apoptosis. Neutralization experiments demonstrated a dominant role of IFN-gamma and Fas-Fas-ligand interaction-mediated suicide in T(H)1 cell AICD.
CONCLUSION: Predominant T(H)2 profile in atopic diseases might be a result of the increased tendency to activation and apoptosis of high IFN-gamma-producing T(H)1 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18328893     DOI: 10.1016/j.jaci.2007.12.1171

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  33 in total

1.  Therapeutic effects of recombinant Salmonella typhimurium harboring CCL22 miRNA on atopic dermatitis-like skin in mice.

Authors:  Won Suck Yoon; Seung Seok Lee; Yang Seok Chae; Yong Keun Park
Journal:  Exp Mol Med       Date:  2011-02-28       Impact factor: 8.718

2.  Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses.

Authors:  Ravi K Viswanathan; William W Busse
Journal:  Chest       Date:  2012-05       Impact factor: 9.410

3.  Neurotransmitter signalling via NMDA receptors leads to decreased T helper type 1-like and enhanced T helper type 2-like immune balance in humans.

Authors:  Kanami Orihara; Solomon O Odemuyiwa; William P Stefura; Ramses Ilarraza; Kent T HayGlass; Redwan Moqbel
Journal:  Immunology       Date:  2017-11-03       Impact factor: 7.397

Review 4.  Pathogenesis of allergic airway inflammation.

Authors:  Devendra K Agrawal; Zhifei Shao
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

5.  Substance P enhances Th17 phenotype in individuals with generalized anxiety disorder: an event resistant to glucocorticoid inhibition.

Authors:  Priscila O Barros; Thais B Ferreira; Morgana M M Vieira; Carla Renata M Almeida; Carlos Fernando Araújo-Lima; Renato G Silva-Filho; Joana Hygino; Regis M Andrade; Arnaldo F Andrade; Cleonice A Bento
Journal:  J Clin Immunol       Date:  2010-09-24       Impact factor: 8.317

Review 6.  Novel developments in the mechanisms of immune tolerance to allergens.

Authors:  Thomas Eiwegger; Saskia Gruber; Zsolt Szépfalusi; Cezmi A Akdis
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

Review 7.  Advances in basic and clinical immunology in 2008.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

8.  Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity.

Authors:  D Hinz; G Seumois; A M Gholami; J A Greenbaum; J Lane; B White; D H Broide; V Schulten; J Sidney; P Bakhru; C Oseroff; E Wambre; E A James; W W Kwok; B Peters; P Vijayanand; A Sette
Journal:  Clin Exp Allergy       Date:  2016-05       Impact factor: 5.018

9.  The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients.

Authors:  Ulisses C Linhares; Patrícia B Schiavoni; Priscila O Barros; Taissa M Kasahara; Bruna Teixeira; Thais B Ferreira; Regina Alvarenga; Joana Hygino; Morgana M M Vieira; Vera Carolina B Bittencourt; Regis M Andrade; Arnaldo F Andrade; Cleonice A M Bento
Journal:  J Clin Immunol       Date:  2012-09-05       Impact factor: 8.317

10.  Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro.

Authors:  Eric R Secor; Anurag Singh; Linda A Guernsey; Jeff T McNamara; Lijun Zhan; Nilanjana Maulik; Roger S Thrall
Journal:  Int Immunopharmacol       Date:  2009-01-20       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.